BCD-261 Phase 1 Study, Healthy Chinese Volunteers
ClinicalTrials.gov Studies
Summary
NIH ClinicalTrials.gov registered a Phase 1 study for investigational drug BCD-261, a single subcutaneous injection, to evaluate safety, pharmacodynamics, pharmacokinetics, and immunogenicity in healthy adult Chinese volunteers. The study (NCT07535775) represents early-stage clinical research.
What changed
NIH added a new clinical trial registration for BCD-261, an investigational drug, on ClinicalTrials.gov. The Phase 1 study will enroll healthy adult Chinese participants to evaluate safety, pharmacokinetics, pharmacodynamics, and immunogenicity following a single subcutaneous injection.
Sponsors conducting clinical trials should ensure accurate registration and results reporting on ClinicalTrials.gov as required under federal law. Clinical investigators should monitor this trial for potential impact on related drug development programs in similar therapeutic areas.
Archived snapshot
Apr 17, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Evaluate Safety, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of BCD-261 After Single Subcutaneous Injection in Healthy Chinese Volunteers
Phase 1 NCT07535775 Kind: PHASE1 Apr 17, 2026
Abstract
The goal of this study is to evaluate the Safety, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of BCD-261 after Single Subcutaneous Injection in Healthy Chinese Volunteers
Conditions: Healthy Adult Participants
Interventions: BCD-261
Related changes
Get daily alerts for ClinicalTrials.gov Studies
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NIH.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov Studies publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.